The antiepileptic drugs (AEDs) market is witnessing consistent growth as the global burden of epilepsy and seizure-related disorders continues to rise. Epilepsy is one of the most common neurological conditions, affecting people of all ages and significantly impacting quality of life if left untreated. Antiepileptic drugs remain the primary line of treatment for...

The landscape of neurological healthcare is undergoing a transformative period, with the global epilepsy drugs market standing at the forefront of this evolution. As medical science transitions from broad-spectrum treatments to precision, patient-centric therapies, the ability to manage and potentially control seizure disorders has reached unprecedented levels of efficacy. According to data...